MAX vs LUNG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 16, 2026

MAX

38.3
AI Score
VS
LUNG Wins

LUNG

60.0
AI Score

Investment Advisor Scores

MAX

38score
Recommendation
AVOID NEW MONEY

LUNG

60score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric MAX LUNG Winner
Forward P/E 5.6402 28.3286 MAX
PEG Ratio 0 0 Tie
Revenue Growth 25.9% -4.6% MAX
Earnings Growth 1412.2% 0.0% MAX
Tradestie Score 38.3/100 60.0/100 LUNG
Profit Margin 7.9% -55.0% MAX
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY BUY LUNG

Relative Price Performance (Last 90 Days)

MAX 1M: +32.2% · 3M: -5.5% LUNG 1M: -6.0% · 3M: +60.7%

Current Technical Phase

MAX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 66

RSI (14): 66.0 · Price: $12.41

LUNG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.1 · Price: $1.88

Fundamentals Snapshot

Metric MAX LUNG
Market Cap — —
Forward P/E 7.4 -2.0
Trailing P/E 7.1 —
Revenue (TTM) — —
Revenue Growth 0.3% 0.0%
Gross Margin 0.1% 0.8%
Operating Margin 0.1% -0.4%
EPS 1.62 -1.15
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, LUNG is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.